Expert Details
Market Access and Riembursement of Orphan Drugs in Europe
ID: 726340
Switzerland
Expert has diverse experience ranging from sales to health economics and reimbursement, combined with an understanding of clinical drug development. Further, with experience spanning both regional and global activities, Expert provides an overall strategic approach while remaining pragmatic and focused on the deliverables.
Expert Consultant GmbH offers senior strategic and hands on completion of deliverables in the field of Market Access, Health Economics, Health Technology Assessment (HTA) and Reimbursement to Pharma/Biotech organisations. Expert offeres a variety of services, including Product Launch, Identify gaps in Reimbursement Strategy, Develop Market Access Plans, Elaborate HTA/reimbursement strategy, Implementation of reimbursement plan for international or local organisations, Preparation of HTA/reimbursement dossiers, Adapt HTA dossiers to local markets, Development of value messages, Producing evidence generation plans to support value messages and HTA/reimbursement plans, Consulting on publication plans to support reimbursement and assessing market access/reimbursement needs for products in any phase of development.
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 1998 | Degree: M.Sc. | Subject: Phamacoepidemiology | Institution: University of Montreal |
| Year: 1987 | Degree: B.Sc. | Subject: Medical Biology | Institution: University of Trois-Rivieres |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 2005 to Present | Employer: Undisclosed | Title: Owner | Department: |
Responsibilities:She assesses potential market oportunities for orphan drugs in Europe and Canada.She develops Market Access Stategy in Europe and Canada She Assists companies to ensure patient access to therapies in development commercially available |
|||
| Years | Employer | Title | Department |
| Years: 2001 to 2005 | Employer: Novartis Pharma AG, Basel, Switzerland | Title: Head | Department: Strategic Pricing and Health Economics |
Responsibilities:She provided international product teams with recommendations for clinical development plans to support pricing and reimbursement argumentation. She conducted pricing studies and developed pricing strategies. She produced the pricing, health economics and reimbursement dossier. |
|||
| Years | Employer | Title | Department |
| Years: 1998 to 2001 | Employer: The Lewin Group, Quintiles, Montreal, Canada | Title: Vice President, Canadian Operations | Department: Pharmacoeconomics and Outcomes Research |
Responsibilities:She managed and operated a consulting firm of 8 Canadian employees. She promoted the various services offered by the firm. She developed proposals, negotiated budgets and contracts for clients. She managed the financial, material and human resources of the firm. |
|||
| Years | Employer | Title | Department |
| Years: 1995 to 1998 | Employer: Pfizer Canada Inc., Montreal, Canada | Title: Manager | Department: Healthcare Economics |
Responsibilities:Available upon request. |
|||
Language Skills
| Language | Proficiency |
|---|---|
| French |